Carboxypeptidases

DBCAT001911Therapeutic category

Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. A DrugBank category of 2 drugs. 1 of them is approved.

Drugs: Alunacedase alfa
Glucarpidase

What you can answer from here — as of September 15, 2022

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

3Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Carboxypeptidases share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account